The Kroger Co (KR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Achieved solid Q1 2024 results with grocery and digital channels driving growth, offsetting weaker fuel and health/wellness segments; customer visits and household counts increased due to strong store execution and omni-channel experience.
Digital sales grew over 8% year-over-year, led by double-digit growth in delivery and pickup; digitally engaged households rose 9% and digital coupon downloads increased 18%.
Launched new Field & Vine berry brand, introduced 346 new Our Brands items, and achieved record quarterly floral sales and pickup fill rate.
Announced sale of Kroger Specialty Pharmacy for $485M, with assets classified as held for sale and a $31M non-recurring tax benefit recognized.
Advanced Albertsons merger with amended divestiture agreement, increasing store divestitures to 579 to address antitrust concerns.
Financial highlights
Q1 2024 sales were $45.3B, up 0.2% year-over-year; identical sales excluding fuel grew 0.5%.
Adjusted FIFO operating profit was $1.499B, down from $1.669B last year; adjusted EPS was $1.43, down from $1.51.
Gross margin was 22.4% of sales; FIFO gross margin rate (ex-fuel) decreased 7 basis points, mainly due to lower pharmacy margins and increased price investments.
LIFO charge was $41M, down from $99M in the prior year quarter.
Dividend per share increased to $0.29 from $0.26 year-over-year.
Outlook and guidance
Reaffirmed full-year 2024 guidance: identical sales without fuel growth of 0.25%–1.75%, adjusted FIFO operating profit of $4.6–$4.8B, and adjusted EPS of $4.30–$4.50.
Adjusted free cash flow projected at $2.5–$2.7B; capital expenditures of $3.4–$3.6B; tax rate expected at 23%.
Margin expansion expected to offset pharmacy headwinds, with improvement anticipated in the second half of 2024.
Inflation expected to remain slightly above 1% for the year, with no broad-based deflation.
Latest events from The Kroger Co
- Digital and pharmacy gains drove Q3 growth; Albertsons merger ended, $7.5B buyback announced.KR
Q3 20258 Jul 2026 - Q1 2026 saw higher sales, 1% identical sales growth, and strong eCommerce profitability.KR
Q1 202726 Jun 2026 - Board elections, key proposals, and an 11% dividend increase highlighted; GHG proposal defeated.KR
AGM 202625 Jun 2026 - Annual meeting covers director elections, pay, auditors, and a GHG report proposal.KR
Proxy filing13 May 2026 - Board recommends all management proposals, highlights strong results, and opposes GHG proposal.KR
Proxy filing13 May 2026 - Adjusted EPS and operating profit rose, with robust eCommerce and share repurchases in 2025.KR
Q4 202628 Apr 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026